U.S. approves GSK's purchase of Novartis vaccine business-companies
November 26, 2014 at 14:35 PM EST
WASHINGTON, Nov 26 (Reuters) - GlaxoSmithKline won U.S. antitrust approval to buy Novartis AG's vaccine business, with the exception of influenza vaccines, the two companies said on Wednesday.